Bear of the Day: Walgreen (WAG)

Walgreen Company (WAG) posted third quarter fiscal 2010 earnings per share of $0.47, lower than the Zacks Consensus Estimate of $0.57 and year-ago quarter s $0.53. Walgreen’s strategy of store expansion coupled with operating acumen has made the company a leader in the retail drug store industry.

However, we are concerned about the competitive pressures faced by the company due to prescription reimbursement issues and slow introduction of new generic products. Moreover, our apprehensions are further bolstered by factors like higher SG&A expenses, a shift towards the low-margin pharmacy business as well as gross margins reflecting a downward trend.

Based on these factors, we have lowered our estimates for fiscal 2011 and downgrade the stock to Underperform with a target price of $26.00.

WALGREEN CO (WAG): Free Stock Analysis Report

About Zacks Investment Research 1767 Articles

Zacks Investment Research is one of the most highly regarded firms in the investment industry. In 1978 Zacks originated the concept of utilizing earnings estimates revisions to make profitable investment decisions. Zacks offers multiple investment products and services to help investors achieve superior returns.


Be the first to comment

Leave a Reply

Your email address will not be published.